Molecular Templates, Inc. (MTEM) Financials

MTEM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 44.1 million 37.3 million
2023-06-30 35.5 million 44.2 million
2023-03-31 78.5 million 80.4 million
2022-12-31 97.5 million 112.7 million

MTEM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.5 million 1.2 million
2023-06-30 -9.7 million 1.8 million
2023-03-31 -19.5 million 2.3 million
2022-12-31 -18.7 million 2.6 million

MTEM Net Income

No data available :(

MTEM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 15.8 million - 12.8 million
2023-06-30 5.0 million - 13.4 million
2023-03-31 41.7 million - 11.6 million
2022-12-31 61.0 million - 14.4 million

MTEM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 5.1 million
2023-06-30 3.8 million
2023-03-31 56.4 million
2022-12-31 56.4 million

MTEM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 5.7 million 4.3 million -
2023-06-30 17000 13.4 million 5.2 million -
2023-03-31 183000 19.0 million 5.8 million -
2022-12-31 312000 17.6 million 6.1 million -

MTEM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 6.8 million 1.5 million
2023-06-30 6.6 million 13.4 million
2023-03-31 33.6 million 19.0 million
2022-12-31 2.6 million 2.1 million

MTEM

Price: $1.72

52 week price:
1.47
9.45

Earnings Per Share: -1.80 USD

P/E Ratio: -0.50

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 75100

Ebitda: -5.8 million

Market Capitalization: 12.4 million

Links: